Advertisement
Screener

CAMP4 Therapeutics Corporation (CAMP) Other

CAMP4 Therapeutics Corporation Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, par value $0.0001 per share · CAMP · Nasdaq Global Market.
  • 2025-03-27: Form 10-K; Item Stock registered under Section 12(b); As filed Common stock, par value $0.0001 per share · CAMP · Nasdaq Global Market.
  • 2024-11-21: Form 10-Q; Item Current in its reporting; As filed No.
FiledFormItemAs filed
2026-03-0510-KStock registered under Section 12(b)Common stock, par value $0.0001 per share · CAMP · Nasdaq Global Market
2025-03-2710-KStock registered under Section 12(b)Common stock, par value $0.0001 per share · CAMP · Nasdaq Global Market
2024-11-2110-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51